Of 1,578 patients with colorectal cancer at Sri Lanka's National Cancer Institute in 2016 to 2020, 58% had stage III or IV disease; 82% of stage III colon cancer patients got adjuvant chemotherapy, but only 50% of stage III rectal cancer patients got neoadjuvant chemoradiotherapy.
Published as "Colorectal Cancer Treatment Characteristics and Concordance With Guidelines in Sri Lanka: Results From a Hospital-Based Cancer Registry". All adults diagnosed with colorectal cancer in 2016 to 2020 were identified from the National Cancer Institute Sri Lanka registry, staged by TNM seventh edition, and treatment was compared with guideline recommendations.
Late stage at diagnosis and gaps in rectal cancer treatment are the main problems the authors identify; the National Cancer Control Programme's 2024 report calls colorectal cancer the third most prevalent cancer in Sri Lanka since 2021.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/